William Ackman may now have enough votes to call a special Allergan, Inc. (NYSE:AGN) shareholder meeting in December, he said in a statement released Friday. It might now matter, says Allergan, as they are planning on holding a special shareholder meeting in December anyway.
Allergan defending itself from Ackman and Valeant
The game of tit for tat, that is the Allergan, Inc. (NYSE:AGN) fight to stave off acquisition by Ackman and Valeant Pharmaceuticals Intl Inc (NYSE:VRX), could result in some finality one way or another, before the end of the year. On Friday Ackman announced he has the support of 39 percent of
Setup a free account to get access to this article (no credit card required).Login required to continue reading.
Already a member? Log in here
